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Strengths and limitations of this study
 ► The frailty measurement studied has only minor de-
viations from a widely recognised instrument used 
in the Senior Health in Ageing and Retirement study 
in Europe.
 ► The frailty measurement was studied in a large rep-
resentative population.
 ► The Lolland-Falster Health Study is cross-sectional 
but by coupling with national registries, we were 
able to follow the participants over time.
 ► Due to lack of follow-up data concerning morbidity, 
we assessed associations between morbidity and 
frailty by using data on morbidity during a period of 
6 months before the frailty measurement.
AbStrACt
Objectives Frailty is a major clinical geriatric syndrome 
associated with serious adverse events including 
functional disability, falls, hospitalisation, increased 
morbidity and mortality. The aim of this study was to 
study associations between a frailty phenotype and frailty 
characteristics well known from the literature.
Design Registry-based cross-sectional study.
Setting The target population consists of inhabitants 
above the age of 50 living in the Danish municipalities of 
Lolland and Guldborgsund. Excluded are incapacitated 
people, inhabitants unable to understand Danish or English 
and inhabitants without a permanent residence.
Participants 7327 individuals aged 50+ years were 
included.
Outcome measures We examined associations 
between the frailty measurement and factors known to 
be associated with frailty: sex, age, income insufficiency, 
education, comorbidity, self-assessed health, morbidity 
and mortality.
results 7327 individuals aged 50+ years were included. 
Of these, 6.5% had ≥3 frailty components (frail), 46.7% 
had 1–2 components (prefrail) and 46.9% had none 
(non-frail). Those who were frail were older and more 
likely female than those who were non-frail or prefrail. 
There was a stepwise decrease in educational level, and 
in self-assessed health with increasing frailty status, and 
a stepwise increase in difficulty in making ends meet, 
number of hospital contacts and mortality with increasing 
frailty status, p<0.0001 for each comparison. Compared 
with individuals who were non-frail, mortality was higher 
among those who were prefrail (HR: 2.90; 95% CI: 1.30 to 
6.43) or frail (HR: 8.21; 95% CI: 3.37 to 20.0).
Conclusions Based on these findings, we consider the 
Lolland-Falster Health Study frailty assessment a valid 
instrument demonstrating the same characteristics as 
other validated frailty measures concerning associations 
with sex, age, income insufficiency, education, comorbidity, 
self-assessed health, morbidity and mortality.
trial registration number NCT02482896.
bACkgrOunD
Frailty is a major clinical geriatric syndrome 
associated with serious adverse outcomes 
including functional disability, falls, 
hospitalisation, increased morbidity and 
mortality. The pathophysiology of frailty 
includes age-related decline in the function 
of multiple organ systems leading to insuffi-
cient homeostatic mechanisms and thereby 
increased vulnerability to minor stressor 
events.1 Two principally different approaches 
are used in order to operationalise the 
measurement of frailty. Fried et al described 
a physical frailty phenotype based on five 
criteria including exhaustion (fatigue), 
weight loss (unintentional), weakness, slow-
ness and low activity. Individuals fulfilling 
three or more of the five criteria are defined as 
frail and individuals fulfilling 1–2 as prefrail.2 
If an individual is frail according to the phys-
ical frailty phenotype, it is not necessarily 
obvious without measurement of the five 
included criteria. In contrast, Mitnitski et al 
described frailty as an accumulation of health 
deficits occurring with ageing and operation-
alised this approach in the frailty index.3 A 
frailty index consists of a predefined list of 
deficits. The proportion of deficits present in 
a specific person defines the frailty index. If 
for instant the chosen list of deficits consists 
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of 50 items, of which the individual has 10, the frailty 
index of this individual is 10/50=0.2. The frailty index 
includes traditional health items like medical diagnoses 
but also other factors describing cognitive function, social 
circumstances and functional loss. Although there is thus 
no universally accepted operational definition of frailty, 
the Fried frailty phenotype is widely used and validated in 
several studies.4–7
The Senior Health in Ageing and Retirement study 
in Europe (SHARE) is a population study including 
questions, which have been used to develop a Share-
Frailty Instrument (SHARE-FI).8 9Validation studies have 
demonstrated that SHARE-FI is associated with mortality9 
and with loss of functional capacity.10
The SHARE study included in its first wave 1699 
Danish citizens above the age of 50. These participants 
were drawn by the Danish National Institute of Statistics 
in order to reflect the Danish population. The SHARE 
questionnaires were translated into Danish following 
recommendations from the SHARE organisation.11 The 
questions used in the SHARE-FI were chosen retrospec-
tively based on their similarity to the items in the frailty 
phenotype originally developed by Fried et al.2
The Danish population study, the Lolland-Falster 
Health Study (LOFUS),12 includes frailty items almost the 
same as those used in the SHARE-FI.
Epidemiology, morbidity and mortality associated with frailty
A systematic review found the prevalence of frailty among 
individuals aged 65+ varying between 4% and 59.1% 
with an overall weighted prevalence of 10.7%. Preva-
lence increased with age and was higher in women.13 The 
prevalence of frailty in Europe among 7510 participants 
aged 65+ enrolled in SHARE 2004 varied between 8.6% 
(Sweden) and 27.3% (Spain). The prevalence among 
877 Danish participants aged 50–64 years was 3.0% and 
among 635 participants aged 65+ 12.4%0.8
Two meta-analyses including studies using the Fried 
phenotype found significant higher hospitalisation 
risk in frail compared with non-frail elderly individuals 
(OR: 1.49, CI: 1.26 to 1.76),14 and significant increased 
mortality (HR: 1.874, CI: 1.635 to 2.150).15
Objectives
The aim of this study was to examine whether the frailty 
measurement used in LOFUS was able to identify frail 
individuals. We did this by examining to what degree the 
frailty measurement is associated with factors known to 
be associated with frailty: age, sex, multimorbidity, level 
of education, income insufficiency, self-assessed health, 
morbidity and mortality.2 16
DESign AnD PArtiCiPAntS
LOFUS has been described in detail elsewhere.12 In 
summary, it is a household-based cross-sectional study 
including people of all ages. Lolland-Falster consists of 
two islands in the southern part of Denmark. It is a rural 
area where income is lower and life expectancy shorter 
than in the general Danish population. The target popu-
lation for the present substudy consists of inhabitants 
above the age of 50 living in the Danish municipalities 
of Lolland and Guldborgsund. Excluded are incapaci-
tated people, inhabitants unable to understand Danish or 
English and inhabitants without a permanent residence.
The data collection started in February 2016 and is still 
ongoing; with currently 7992 individuals aged 50+ years 
recruited.
MEthODS
Frailty
LOFUS includes the following variables used to assess 
frailty:
1. Exhaustion/Fatigue: the criterion was fulfilled by an-
swering yes in response to the question ‘In the last 
month or so, have you had too little energy to do things 
you wanted to do?’ (Yes/No)
2. Shrinking: the criterion was fulfilled by answering 
yes in response to the question ‘What has your appe-
tite been like? Do you feel a diminution in desire for 
food?’ (Yes/No)
3. Weakness was derived from the highest of three con-
secutive dynamometer measurements of handgrip 
strength in the dominant hand applying gender and 
body mass index cutoffs set by Fried et al.2
4. Slowness: a positive answer to either of the following 
two items ‘Because of a health problem, do you have 
difficulty ([expected to last more than 3 months]) 
walking 100 meters or ‘climbing one flight of stairs 
without resting’?
5. Low activity was fulfilled in participants responding 
one to three times a month, hardly ever or never to the 
question ‘How often do you engage in activities that 
require a low or moderate level of energy such as gar-
dening, cleaning the car, or going for a walk?’
Individuals fulfilling 1–2 of the above-mentioned crite-
ria were characterised as prefrail, while those fulfilling 
3–5 criteria were characterised as frail. If none of the 
criteria were fulfilled, individuals were characterised as 
non-frail.
Factors assessed for association with frailty, data from LOFuS
The following factors were extracted from the LOFUS 
questionnaires: age, sex, self-assessed health, educa-
tional background, financial difficulties, comorbidity and 
mortality. Educational level was categorised according to 
highest obtained education into four categories: ‘primary 
school’, ‘short education’, ‘medium higher education’ 
and ‘long higher education’.
Comorbidity was assessed by asking participants if they 
suffered from angina, migraine or headache, arthritis, 
cancer, diabetes, hypertension, chronic bronchitis, 
emphysema, chronic obstructive pulmonary disease, 
depression, anxiety, kidney disease, asthma, dementia or 
Parkinson’s disease. Socioeconomic status was assessed by 
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Table 1 Prevalence of phenotype frailty components
Total
(n=7327)
Men
(n=3498)
Women
(n=3829)
Frequency of frailty components
  Exhaustion 41.5 38.8 43.9
  Shrinking 6.3 5.0 7.5
  Weakness 8.2 8.1 8.2
  Slowness 12.8 11.8 13.8
  Low activity 12.2 11.1 13.1
Number of frailty components
  0 46.8 49.7 44.2
  1 33.8 32.9 34.6
  2 12.9 11.8 13.9
  3 4.7 4.4 4.9
  4 1.7 1.1 2.1
  5 0.1 0.1 0.2
the question ‘During the last twelve months, how often 
did you find difficulty in making ends meet?’
Data from national health registers
Every person residing in Denmark is uniquely regis-
tered in the Danish Civil Registration System (CRS).17 
The LOFUS database receives daily updates from CRS 
on all inhabitants of Lolland-Falster regarding births, 
deaths, immigration and moving of residents. Individuals 
were followed up in CRS until date of death or February 
2019. Additionally, we assessed data on hospitalisation by 
merging the LOFUS database with the Danish National 
Patient Register.18
Number of hospital contacts was defined as hospital 
contacts within 2 years prior to the date of participa-
tion in LOFUS. Hospital contacts were categorised as 
no admission days registered in the National Patient 
Register (ambulant contacts) or admission days regis-
tered (hospital admission).
Sample size
For the substudy on aging-related outcomes in LOFUS, 
that is among the 50+ year olds, the original idea was to 
study the association between social factors (socioeco-
nomic position and social relations, respectively) and 
physical function and frailty. Initially, we performed 
power calculations for all social variables in relation to 
detection of their impact on physical function as well 
as frailty. The prevalence estimates used in these power 
calculations were calculated from previous Danish popu-
lation surveys applying similar measures, and previous 
literature.16 19 20 Based on these calculations, we requested 
inclusion of 5800 individuals aged 50+, in order to detect 
an association between each of the social variables and 
physical function or frailty at a significance level of 0.05 
and with 80% power. However, based on the power calcu-
lations performed for frailty as dependent variable, we 
only needed 1600 individuals aged 50+ in order to detect 
an association between socioeconomic position and frailty 
at a significance level of 0.05 and with 80% power. There-
fore, we found it feasible to perform this study when 
more than 7000 individuals aged 50+ were included, even 
though the LOFUS study is still recruiting.
Statistical analysis
For associations of frailty phenotype with demographic 
and health characteristics, and hospital contacts, the 
p-trend values based on the Cochran-Mantel-Haenszel test 
was used, using the cmh function in STATA/SE V.15.1. 
For associations between frailty phenotype and mortality, 
the Cox proportional hazard regression model, using 
length of follow-up as the time metric, estimated HRs and 
95% CI. The Cox model was adjusted for age group and 
sex.
Patient and public involvement
Patients and public were not involved in the development 
of this study.
rESuLtS
Of a total of 7992 individuals 50+ years old, 656 (12.2%) 
were excluded as they did not answer the questions on 
frailty. Nine individuals were considered not available for 
frailty measurement as they had three or more missing 
frailty components, leaving 7327 individuals for analysis. 
Of these, 6.5% had ≥3 frailty components, 46.7% had 1–2 
components and 46.8% had none. The most frequent 
frailty component was exhaustion (41.5%), followed 
by slowness (12.8%) and low activity (12.2%) (table 1). 
Overall, 55.8% reported ‘good’ self-assessed health and 
93.6% never had difficulty in making ends meet (table 2).
Those who were frail were older and more likely female 
than those who were non-frail or prefrail. There was 
a stepwise decrease in education level and self-assessed 
health and a stepwise increase in difficulty in making 
ends meet and number of hospital contacts and hospital 
admissions with increasing frailty status, p<0.0001 for 
each comparison. Notably, 14.7% of those who were frail 
had no hospital contacts (table 3).
Frail persons had significantly higher prevalence of 
myocardial infarction, angina, migraine or headache, 
cancer, diabetes, hypertension, respiratory disease, 
depression, anxiety, kidney disease, asthma and dementia. 
Notably, 7.8% of those who were frail had none of these 
chronic diseases and 20.0% had just one which were: 
43.2% arthritis, 21.1% hypertension, 8.4% migraine or 
headache, 7.4% cancer, 6.3% respiratory disease and 
5.3% depression. The remaining chronic diseases were 
each represented by less than 2.5%. Figure 1 shows the 
overlap between frailty and comorbidity.
Mean follow-up time was 1.13 years for all-cause 
mortality, giving a total of 8 314 568 person-years and 
49 deaths (0.7%). Compared with individuals who were 
non-frail, mortality was higher among those who were 
prefrail (HR: 2.90; 95% CI: 1.30 to 6.43) or frail (HR: 
8.21; 95% CI: 3.37 to 20.0) (table 4).
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Table 2 Association of demographic and health characteristics with frailty phenotype
Factors
Total
7327 (%)
Non-frail
3432 (%)
Prefrail
3419 (%)
Frail
476 (%)
Trend,
p value
Age adjusted 
trend, p value
Age
  50–65 3749 (51.2) 1673 (48.8) 1900 (55.6) 176 (37.0) <0.0001
  65–74 2578 (35.2) 1399 (40.8) 1017 (29.7) 162 (34.0)
  75–84 892 (12.2) 342 (10.0) 441 (12.9) 109 (22.9)
  85+ 108 (1.5) 18 (0.5) 61 (1.8) 29 (6.1)
Sex
  Female 3829 (52.3) 1693 (49.3) 1859 (54.4) 277 (58.2) <0.0001 <0.0001
  Male 3498 (47.7) 1739 (50.7) 1560 (45.6) 199 (41.8)
Education
  Primary school 816 (11.1) 295 (8.6) 429 (12.6) 92 (19.3) <0.0001 <0.0001
  Short (1–3 years) 4197 (57.3) 1987 (57.9) 1959 (57.3) 251 (52.7)
  Medium (3–4 years) 1465 (20.0) 737 (21.5) 659 (19.3) 69 (14.5)
  Long (>4 years) 301 (4.1) 162 (4.7) 127 (3.7) 12 (2.5)
Self-assessed health
  Very good 838 (11.5) 626 (18.3) 203 (6.0) 9 (1.9) <0.0001 <0.0001
  Good 4077 (55.8) 2337 (68.2) 1661 (48.7) 79 (16.7)
  Fair 2048 (28.0) 450 (13.1) 1326 (38.9) 272 (57.6)
  Bad 310 (4.2) 13 (0.4) 198 (5.8) 99 (21.0)
  Very bad 32 (0.4) 0 (0.0) 19 (0.6) 13 (2.8)
Difficulty in making ends meet
  Never 6813 (93.6) 3290 (96.4) 3122 (92.1) 401 (84.4) <0.0001 <0.0001
  A few months 353 (4.9) 101 (3.0) 200 (5.9) 52 (11.0)
  Approximately half of a year’s 
months
54 (0.7) 9 (0.3) 31 (0.9) 14 (3.0)
  Every month 58 (0.8) 13 (0.4) 37 (1.1) 8 (1.7)
Chronic diseases
  Myocardial infarction 296 (4.0) 96 (2.8) 161 (4.7) 39 (8.2) <0.0001 <0.0001
  Angina 241 (3.3) 56 (1.6) 132 (3.9) 53 (11.1) <0.0001 <0.0001
  Migraine or headache 842 (11.5) 234 (6.8) 516 (15.1) 92 (19.3) <0.0001 <0.0001
  Arthritis 2849 (38.9) 1025 (29.9) 1538 (45.0) 286 (60.1) <0.0001 <0.0001
  Cancer 379 (5.2) 137 (4.0) 193 (5.6) 49 (10.3) <0.0001 <0.0001
  Diabetes 525 (7.2) 154 (4.5) 285 (8.3) 86 (18.1) <0.0001 <0.0001
  Hypertension 2425 (33.1) 969 (28.2) 1227 (35.9) 229 (48.1) <0.0001 <0.0001
  Respiratory disease* 429 (5.9) 100 (2.9) 234 (6.8) 95 (20.0) <0.0001 <0.0001
  Depression 548 (7.5) 104 (3.1) 331 (9.7) 113 (23.7) <0.0001 <0.0001
  Anxiety 426 (5.8) 92 (2.7) 256 (7.5) 78 (16.4) <0.0001 <0.0001
  Kidney disease 122 (1.7) 31 (0.9) 66 (1.9) 25 (5.3) <0.0001 <0.0001
  Asthma 425 (5.8) 135 (3.9) 225 (6.6) 65 (13.7) <0.0001 <0.0001
  Dementia 21 (0.3) 4 (0.12) 13 (0.4) 4 (0.8) 0.01 0.03
  Parkinson’s disease 45 (0.6) 18 (0.5) 23 (0.7) 4 (0.8) 0.59 0.72
Chronic diseases
  0 2238 (30.5) 1408 (41.0) 793 (23.2) 37 (7.8) <0.0001 <0.0001
  1 2415 (33.0) 1214 (35.4) 1106 (32.4) 95 (20.0)
  2 1537 (21.0) 569 (16.6) 845 (24.7) 123 (25.8)
  3–4 971 (13.3) 224 (6.5) 585 (17.1) 162 (34.0)
  >5 166 (2.3) 17 (0.5) 90 (2.6) 59 (12.4)
*Includes chronic bronchitis, emphysema, andchronic obstructive pulmonary disease.
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Table 3 Association between number of hospital contacts and frailty status
Category
Total
7327 (%)
Non-frail
3432 (%)
Prefrail
3419 (%)
Frail
476 (%)
Trend,
p value
Age adjusted 
trend, p value
Ambulatory contacts
  0 3088 (42.2) 1628 (47.4) 1312 (38.4) 148 (31.1) <0.0001 <0.0001
  <5 3893 (53.1 1696 (49.4) 1908 (55.8) 289 (60.7)
  5–10 335 (4.6) 105 (3.1) 193 (5.6) 37 (7.8)
  >10 11 (0.2) <5 6 (0.2) <5
Hospital admissions
  0 3471 (47.4) 1865 (53.3) 1470 (43.0) 136 (28.6) <0.0001 <0.0001
  <5 2987 (40.8) 1299 (37.9) 1464 (42.8) 224 (47.1)
  5–10 727 (9.9) 235 (6.9) 402 (11.8) 90 (18.9)
  >10 142 (1.9) 33 (1.0) 83 (2.4) 26 (5.5)
Hospital stay, number of days
  0 3471 (47.4) 1865 (54.3) 1470 (43.0 136 (28.6) <0.0001 <0.0001
  <5 2329 (31.8) 1062 (30.9) 1121 (32.8) 146 (30.7)
  5–10 889 (12.1) 324 (9.4) 473 (13.8) 92 (19.3)
  >10 638 (8.7) 181 (5.3) 355 (10.4) 102 (21.4)
Figure 1 Venn diagram displaying extent of overlap of 
frailty with multimorbidity (≥2 chronic diseases) in the 
Lolland-Falster Health Study. Total represented by 2674 
individuals with frailty and/or multimorbidity. Percentages are 
percentages of individuals with frailty (n=476). Frailty is based 
on the criteria characterising the frailty phenotype described 
by Fried et al.2
Table 4 Frailty status and mortality
Number of 
deaths
Mortality
HR (95% CI)
Non-frail (reference 
group)
8 1.00
Prefrail 26 2.90 (1.30 to 6.43)
Frail 15 8.21 (3.37 to 20.0)
DiSCuSSiOn
In this study, we aimed at examining whether the frailty 
measurement used in a Danish population study was able 
to identify frail individuals. The frailty instrument used is 
based on the criteria characterising the frailty phenotype 
described by Fried et al.2 Our frailty measurement builds 
on the work by Santo-Eggimann et al, which showed that 
a subset of questions in the SHARE could be operation-
alised as a frailty measurement.8 Romero-Ortuno et al 
further developed this approach into the SHARE-FI and 
validated this instrument in several studies.9 21–23 The 
frailty items used in LOFUS were almost identical to those 
included in SHARE-FI.
We have examined to what degree our frailty measure-
ment was associated with factors already known to be 
associated with frailty: age, sex, multimorbidity, level of 
education, income insufficiency, self-assessed health and 
mortality.
Higher levels of education and income sufficiency were 
protective factors. Being female, of higher age and having 
more comorbidity were associated with increasing frailty. 
These findings are in agreement with a large number of 
other frailty studies.2 16 Due to present lack of follow-up 
data, we could not test the predictive value concerning 
morbidity. We therefore decided to examine the associ-
ation between frailty and number of hospitalisations in a 
2-year period previously to the frailty measurement and 
found a significant trend with an increasing number of 
hospital contacts with increasing frailty. We only had a 
short follow-up period to examine mortality (1.13 years) 
but in spite of this, there was a significant increasing 
mortality rate with increasing frailty.
Overall, we found the prevalence of frailty to be 6.5%. 
In the age group 50–64, it was 4.7% and in the 65+, it was 
8.4%. This is an overall lower prevalence and a different 
pattern than what was seen in the group of Danish SHARE 
participants, in which the overall prevalence was 8.8%, in 
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the 50–64 years 3%, and in the 65+ years old 12.4%. The 
explanation might be that our study is taking place in a 
rural area with a relatively high proportion of socioeco-
nomically deprived individuals in the younger age groups, 
while the Danish participants in SHARE were drawn 
randomly in order to select a representative sample of 
Danes from the whole country in these age groups. The 
population covered by LOFUS compared with the general 
Danish population has lower income, less education, 
higher burden of disease, higher prevalence of unhealthy 
lifestyle factors and an average life expectancy approxi-
mately 2 years lower than mean average life expectancy in 
Denmark (80.8 years).12This could result in higher prev-
alence of frailty in the youngest age groups due to high 
burden of risk factors, and a lower prevalence in the older 
age groups due to selection leading to a healthy survivor 
effect.24
The overall lower prevalence compared with SHARE 
might also be explained by characteristics of non-re-
spondents in LOFUS. Halfway through the LOFUS data 
collection subjects with lower socioeconomic status and 
age above 80 were found to have lower participation rates 
compared with more well off and younger age groups 
(article in press). This implicates that our study may 
underestimate the prevalence of frailty.
The prevalence of 0, 1, 2, 3, 4 or 5 frailty criteria was 
very similar to the findings by Fried et al.2 The distribu-
tion of prevalence of the single frailty criteria has been 
differing in several studies. In our study, we found a 
very high prevalence of exhaustion 41.5% versus 17% in 
the study by Fried et al2 and 27% in the cross European 
study by Santos-Eggimann et al.8 The way we measured 
exhaustion was exactly the same way as Santos-Eggiman 
by asking: ‘In the last month or so, have you had too little 
energy to do things you wanted to do?’ and in case of a 
‘Yes’ this criteria was considered fulfilled. Fried et al used 
a more detailed report from the participants based on 
answers from two items from the modified 10-item Centre 
for Epidemiology Studies Depression Scale25 and this may 
explain some of the rather large difference in prevalence 
of the exhaustion criteria. We found a distribution of 
prevalence for the criteria slowness, weakness and phys-
ical activity similar to the findings by Eggimann et al but 
again somewhat different from the findings by Fried et 
al. This may be due to the fact that Fried et al defined 
the cut-off values for these frailty criteria according to the 
population assessed by defining the criteria fulfilled if the 
values were included in the lowest quintile of the study 
sample distribution. Bouzòn et al recently showed that the 
standardisation to the population assessed makes a differ-
ence for the predictive ability of the frailty diagnosis.26
Strengths and limitations
Our study is a large population study with a representa-
tive sample for the geographical area covered by LOFUS. 
At the present, LOFUS is a cross-sectional study; however, 
due to the national health registries, we were able to 
follow the participants over a time period. The Danish 
registries are of high quality and the unique personal 
identification numbers of all Danish inhabitants made 
it possible to include valid data concerning morbidity 
(hospital contacts) and mortality.27 Due to the present 
lack of follow-up data concerning morbidity, we had 
to assess hospital contacts in a period before the frailty 
measurement instead of assessing the predictive ability 
concerning hospital contacts. However, frailty is consid-
ered a syndrome developing over time and not evolving 
as an acute event. We therefore consider the findings of 
association with previous hospital contacts equally valu-
able compared with an association with future hospital 
contacts.
COnCLuSiOn
We have described a frailty instrument that has only 
minor deviations from the frailty instrument developed in 
a large European population study, SHARE (SHARE-FI). 
Our frailty instrument shows the same characteristics 
as the SHARE-FI and other validated frailty measures 
concerning associations with sex, age, income insuf-
ficiency, education, comorbidity, self-assessed health, 
multimorbidity and mortality. Based on these findings, we 
consider our frailty measure a valid instrument.
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